Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2014

01.02.2014 | Head and Neck Oncology

Postoperative Nomograms Predictive of Survival After Surgical Management of Malignant Tumors of the Major Salivary Glands

verfasst von: Safina Ali, MD, Frank L. Palmer, BA, Changhong Yu, MS, Monica DiLorenzo, BA, Jatin P. Shah, MD, Michael W. Kattan, PhD, Snehal G. Patel, MD, Ian Ganly, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The objective of this study was to create a nomogram predictive of survival in salivary gland cancer.

Methods

Clinical, tumor, and treatment characteristics were collected for 301 patients who underwent surgery for salivary gland cancer between 1985 and 2009 at Memorial Sloan Kettering Cancer Centre. Factors predictive of overall survival (OS) and cancer-specific survival (CSS) were determined by univariate analysis. Cox risk regression was used to model OS data. Competing risks regression was used for cancer-specific death. Deaths from other causes were treated as competing risks for cancer-specific death. Predictive nomograms for OS and CSS were then created using stepdown method to select predictors of outcome.

Results

The median age was 62 (range 9–89) years. There were 156 (52 %) males and 145 (48 %) females. Five variables predictive for OS (age, clinical T4 stage, histological grade, perineural invasion, and tumor dimension) were used to generate a parsimonious model, and a nomogram was created to predict 10-year survival probability. The concordance index (CI) for this nomogram was 0.809. Five variables predictive for CSS (histological grade, perineural invasion, clinical T4 stage, positive nodal status, and status of margins) were used to generate a second nomogram predicting CSS. This nomogram had a CI of 0.856. Both nomograms were validated internally by assessing discrimination and calibration.

Conclusions

We have developed the first nomograms to predict prognosis in an individual patient with salivary gland cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Spitz MR, Batsakis JG. Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol. 1984;110(1):45–9.PubMedCrossRef Spitz MR, Batsakis JG. Major salivary gland carcinoma. Descriptive epidemiology and survival of 498 patients. Arch Otolaryngol. 1984;110(1):45–9.PubMedCrossRef
2.
Zurück zum Zitat Barnes LEJ, Reichart P, Sidransky D. Pathology and genetics of head and neck tumours. Lyon: World Health Organization Classification of Tumours: IARC Press; 2005. Barnes LEJ, Reichart P, Sidransky D. Pathology and genetics of head and neck tumours. Lyon: World Health Organization Classification of Tumours: IARC Press; 2005.
3.
Zurück zum Zitat Sobin LH. TNM: evolution and relation to other prognostic factors. Semin Surg Oncol. 2003;21(1):3–7.PubMedCrossRef Sobin LH. TNM: evolution and relation to other prognostic factors. Semin Surg Oncol. 2003;21(1):3–7.PubMedCrossRef
4.
Zurück zum Zitat Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4.PubMedCrossRef Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4.PubMedCrossRef
6.
Zurück zum Zitat Kattan MW. Nomograms. Introduction. Semin Urol Oncol. 2002;20(2):79–81.PubMed Kattan MW. Nomograms. Introduction. Semin Urol Oncol. 2002;20(2):79–81.PubMed
7.
Zurück zum Zitat Kattan MW, Stapleton AM, Wheeler TM, Scardino PT. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer. 1997;79(3):528–37.PubMedCrossRef Kattan MW, Stapleton AM, Wheeler TM, Scardino PT. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer. 1997;79(3):528–37.PubMedCrossRef
8.
Zurück zum Zitat Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol. 2003;13(2):111–6.PubMedCrossRef Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol. 2003;13(2):111–6.PubMedCrossRef
9.
Zurück zum Zitat Lee HS, Kim SW, Kim BH, et al. Predicting nonsentinel lymph node metastasis using lymphoscintigraphy in patients with breast cancer. J Nucl Med. 2012;53(11):1693–700.PubMedCrossRef Lee HS, Kim SW, Kim BH, et al. Predicting nonsentinel lymph node metastasis using lymphoscintigraphy in patients with breast cancer. J Nucl Med. 2012;53(11):1693–700.PubMedCrossRef
10.
Zurück zum Zitat Gross ND, Patel SG, Carvalho AL, et al. Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma. Head Neck. 2008;30(10):1352–60.PubMedCrossRef Gross ND, Patel SG, Carvalho AL, et al. Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma. Head Neck. 2008;30(10):1352–60.PubMedCrossRef
11.
Zurück zum Zitat Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol. 2005;12(8):654–9.PubMedCrossRef Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol. 2005;12(8):654–9.PubMedCrossRef
12.
Zurück zum Zitat Marko NF, Xu Z, Gao T, Kattan MW, Weil RJ. Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models. Cancer. 2012;118(15):3749–57.PubMedCrossRef Marko NF, Xu Z, Gao T, Kattan MW, Weil RJ. Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models. Cancer. 2012;118(15):3749–57.PubMedCrossRef
13.
Zurück zum Zitat Ross PL, Gerigk C, Gonen M, et al. Comparisons of nomograms and urologists’ predictions in prostate cancer. Semin Urol Oncol. 2002;20(2):82–8.PubMedCrossRef Ross PL, Gerigk C, Gonen M, et al. Comparisons of nomograms and urologists’ predictions in prostate cancer. Semin Urol Oncol. 2002;20(2):82–8.PubMedCrossRef
14.
Zurück zum Zitat Kawachi MH, Bahnson RR, Barry M, et al. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Cancer Netw. 2010;8(2):240–62. Kawachi MH, Bahnson RR, Barry M, et al. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Cancer Netw. 2010;8(2):240–62.
15.
Zurück zum Zitat van Buuren S. Multivariate Imputation by Chained Equations in R. J Stat Softw. 2011;45(3):1–67. van Buuren S. Multivariate Imputation by Chained Equations in R. J Stat Softw. 2011;45(3):1–67.
16.
Zurück zum Zitat Cheung MC, Franzmann E, Sola JE, Pincus DJ, Koniaris LG. A comprehensive analysis of parotid and salivary gland cancer: worse outcomes for male gender. J Surg Res. 2011;171(1):151–8. Cheung MC, Franzmann E, Sola JE, Pincus DJ, Koniaris LG. A comprehensive analysis of parotid and salivary gland cancer: worse outcomes for male gender. J Surg Res. 2011;171(1):151–8.
17.
Zurück zum Zitat Boukheris H, Curtis RE, Land CE, Dores GM. Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18(11):2899–906.PubMedCentralPubMedCrossRef Boukheris H, Curtis RE, Land CE, Dores GM. Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18(11):2899–906.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Fe H. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis: New York: Springer; 2001. Fe H. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis: New York: Springer; 2001.
19.
Zurück zum Zitat Fine JP and Gray RJ. A proportional hazards model for the subdistribution of a competing risk. JASA. 1999;94:496–509.CrossRef Fine JP and Gray RJ. A proportional hazards model for the subdistribution of a competing risk. JASA. 1999;94:496–509.CrossRef
20.
Zurück zum Zitat Barlin JN, Yu C, Hill EK, et al. Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer. Gynecol Oncol. 2012;125(1):25–30.PubMedCrossRef Barlin JN, Yu C, Hill EK, et al. Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer. Gynecol Oncol. 2012;125(1):25–30.PubMedCrossRef
21.
Zurück zum Zitat Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010;28(23):3762–9.PubMedCrossRef Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010;28(23):3762–9.PubMedCrossRef
22.
Zurück zum Zitat Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2005;23(28):7005–12.PubMedCentralPubMedCrossRef Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2005;23(28):7005–12.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240(2):293–8.PubMedCrossRef Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240(2):293–8.PubMedCrossRef
Metadaten
Titel
Postoperative Nomograms Predictive of Survival After Surgical Management of Malignant Tumors of the Major Salivary Glands
verfasst von
Safina Ali, MD
Frank L. Palmer, BA
Changhong Yu, MS
Monica DiLorenzo, BA
Jatin P. Shah, MD
Michael W. Kattan, PhD
Snehal G. Patel, MD
Ian Ganly, MD
Publikationsdatum
01.02.2014
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2014
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-013-3321-y

Weitere Artikel der Ausgabe 2/2014

Annals of Surgical Oncology 2/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.